Nine of 11 patients in new brain cancer trial saw their tumors shrink by at least half. One really beat the odds.

ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic ... received Glamour’s 2024 Health and Wellness award for Best ...

Medically reviewed by Jurairat J. Molina, MD Acute urticaria (hives) is a common skin condition that affects up to 20% of people at some point in their lives. It can transition into chronic urticaria ...